# BridgeBio Oncology Therapeutics, Inc.: Form S-1/A, filed Feb 7, 2024

- Company: [BridgeBio Oncology Therapeutics, Inc.](/companies/bbot.md) (CIK 1869105)
- Form: S-1/A
- Filed: 2024-02-07
- Accepted by EDGAR: Feb 6, 2024, 21:18 ET
- Period: not reported
- Accession: 0001213900-24-010676
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1869105/000121390024010676/fs12024a2_helixacq2.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1869105/000121390024010676/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1869105/000121390024010676/fs12024a2_helixacq2.htm

Filed Feb 7, 2024.
Source: SEC EDGAR, the filing index for accession 0001213900-24-010676. Last ingested by Listed: Nov 11, 2026, 01:13 ET. No prices; not investment advice.